Nasal residence time and rheological properties of a new bentonite-based thixotropic gel emulsion nasal spray - AM-301.

Nose bentonite disitribution medical device mucosal deposition nasal residence time nasal spray rheology rhinoscopy thixotropic viscoelastic properties

Journal

Drug development and industrial pharmacy
ISSN: 1520-5762
Titre abrégé: Drug Dev Ind Pharm
Pays: England
ID NLM: 7802620

Informations de publication

Date de publication:
Jan 2023
Historique:
pubmed: 1 3 2023
medline: 23 3 2023
entrez: 28 2 2023
Statut: ppublish

Résumé

The present work provides characterization of rheological properties of a new bentonite-based thixotropic gel emulsion nasal spray (AM-301), its nasal residence time, distribution, safety and tolerability. The nasal epithelium is a portal of entry for allergens and primary infection by airborne pathogens. Non-pharmacological interventions, which enhance physical and biological barriers, protect against allergens and pathogens without drug-related side effects. AM-301 has shown promising efficacy and safety in the nasal epithelium against viruses ( Technical part (i) spray characterization was performed with a validated droplet size distribution method; evaluation of the rheological properties of the formulation was performed by a validated amplitude sweep method and a validated oscillation, rotation, oscillation; Clinical part (ii) nasal and oropharyngeal endoscopy were used to provide a semi-quantitative evaluation of distribution and residence time of fluorescein-labelled AM-301 in the nose and oropharynx of healthy volunteers; (iii) tolerability and safety. (i) The non-Newtonian rheological properties of the formulation allow AM-301 to be sprayed and then to revert to a gel to prevent run-off from the nasal cavity; (ii) the formulation remains on the inferior turbinate, septum and oropharynx of volunteers for up to 210 min and on the middle turbinate for up to 60 min; two nasal sprays provide no substantial benefit over a single application with regards to coverage or retention; (iii) the spray is well tolerated. Single dose spray delivery of AM-301 provides extended coverage of the nasal mucosa up to the inferior turbinates.

Identifiants

pubmed: 36852769
doi: 10.1080/03639045.2023.2183724
doi:

Substances chimiques

Nasal Sprays 0
Bentonite 1302-78-9
Emulsions 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103-114

Auteurs

Martin M Sailer (MM)

Department of Otorhinolaryngology, Head and Neck Surgery, St. Trudpert SILOAH Medical Center Pforzheim, Pforzheim, Germany.

Melanie Köllmer (M)

RaDes GmbH, Hamburg, Germany.

Beatrice Masson (B)

IDD-Xpert, Evreux, France.

Fabio Fais (F)

Altamira Medica AG, Zug, Switzerland.

Ilja P Hohenfeld (IP)

Altamira Medica AG, Zug, Switzerland.

Michael E Herbig (ME)

RaDes GmbH, Hamburg, Germany.

Assen K Koitschev (AK)

Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center of Eberhard-Karls University Tübingen, Germany, Tübingen, Germany.

Sven Becker (S)

Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center of Eberhard-Karls University Tübingen, Germany, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH